Health Decisions Welcomes KLIXAR into the Agile Clinical Network
Health Decisions (Durham, NC) has a new company in its Agile Clinical Network, a community of research partners with the goal of higher efficiency standards in complex global studies.KLIXAR, an Argentinian CRO, has received certification after completing "rigorous" training in Agile Clinical development techniques.
“Our alliance with Health Decisions will enable us to broaden our customer base while providing unparalleled efficiency and transparency to pharmaceutical companies in Latin America,” said said Enrique Gaubeca, managing director at KLIXAR, in a company press release.
As part of the newly launched Network, KLIXAR will have access to Health Decisions’ data management systems, biostatistics expertise, medical writers, advanced data collection tools, and real-time reporting capabilities.
"We look forward to working with KLIXAR and all our Agile Clinical Network partners to raise the standards of efficiency for global clinical trials," said Rick Farris, COO at Health Decisions. "By producing rapid, accurate results for our sponsors regardless of geographic boundaries, we hope to shape the future of drug development..."
For more information about the Network, click here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.
